Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg as an Oral Contraceptive: A Viewpoint by Paula Bednarek

By Bednarek Paula  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2478-2479

Adis International

Access to resources Recommend Favorite

User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice: A Multi-Country, Questionnaire-Based Study

By Short Mary  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 153-159

Adis International

Access to resources Recommend Favorite

Ethinylestradiol/levonorgestrel: continuous comparable to cyclic

By  

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Cycle Control and Bleeding Pattern of a 24/4 Regimen of Drospirenone 3 mg/Ethinylestradiol 20 μg Compared with a 21/7 Regimen of Desogestrel 150 μg/Ethinylestradiol 20 μg: A Pooled Analysis

By Anttila Leena  

Clinical Drug Investigation, Vol. 31, Iss. 8, 2011-08 ,pp. : 519-525

Adis International

Access to resources Recommend Favorite

Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects: An Open-Label, Single-Sequence, Single-Centre Study

By Spence Rebecca   Mandagere Arun   Walker Gennyne   Dufton Christopher   Boinpally Ramesh  

Clinical Drug Investigation, Vol. 30, Iss. 5, 2010-05 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite